Redwood City, CA, United States of America

Allakos Inc.


USPTO Granted Patents = 7


Trademarks = 2

Forward Citations = 12

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Christopher Robert Bebbington (7 out of 44 patents)

silverMedal Nenad Tomasevic (7 out of 10 patents)

bronzeMedal Rustom Falahati (4 out of 4 patents)

4.  Bradford Andrew Youngblood (2 out of 2 patents)

5.  Wouter Korver (2 out of 2 patents)

6.  Carolina Rita Sousa Fernandes (1 out of 1 patent)

7.  David John Matthews (1 out of 1 patent)

8.  John Leung (1 out of 1 patent)

9.  Jason Williams (1 out of 2 patents)

10.  Suzy El Bader (1 out of 1 patent)

11.  Kenneth Luehrsen (1 out of 1 patent)

12.  Jason Williams (0 patent)

13.  Carolina Rita Sousa Fernandes (0 patent)

14.  David John Matthews (0 patent)

15.  Carolina Rita Sousa Fernandes (0 patent)


7 patents:

Company Overview
Allakos Inc. is a clinical-stage biotechnology company focused on developing therapeutic antibodies for the treatment of eosinophil and mast cell related diseases. The company's lead product candidate is AK002, which is being studied for the treatment of various allergic and inflammatory conditions. Allakos is committed to improving the lives of patients with severe and rare diseases through innovative drug development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#195 in Redwood City, CA

#9,491 in California

#39,879 in US

Redwood City, CA (US)
Redwood City, CA, United States of America
Forward Citations = 12

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Allakos Inc.. Retrieved from https://idiyas.com/company/allakos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…